ArticleMicrobial cell factories2026
Tailored molecular weight hyaluronic acid production by engineered Lactococcus lactis.
Article in Microbial cell factories, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Comparative evaluation of glucosamine derivatives for enhanced microbial hyaluronic acid production by Streptococcus zooepidemicus and Streptococcus pyogenes.Archives of microbiology · 2026Article
- EngineeringBiomolecules · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHyaluronic acid (HA) is a glycosaminoglycan with a wide range of biological functions that depend on its molecular weight (MW). Recently, there has been an increasing interest in producing HA at particular MWs for various cosmetic and biomedical applications. HA is traditionally produced by extraction or microbial fermentation, which is then subjected to chemical or enzymatic treatments to customize the MW. On the other hand, direct microbial synthesis at desired MWs has considerable advantages over conventional techniques. The present study introduces a combinatorial approach using four critical variables which influence the molecular weight of HA (MWHA): (1) Expression of HA synthases from different Streptococcus species (S. parauberis, S. uberis, S. zooepidemicus, and S. pyogenes) which intrinsically produce different MWHA; (2) Supply of HA precursors by varying heterlogous gene expression in the HA-precursor pathways (hasAB vs. hasABE); (3) Re-routing of metabolic fluxes by deletion of the lactate dehydrogenase (ldh) gene; and (4) Varying the initial glucose concentration in batch fermentation.
resultsRecombinant Lactococcus lactis strains expressing HA synthase genes taken from diverse Streptococcal sp. were found to produce varying MWHA under otherwise identical genetic and bioreactor conditions. The HA synthases sourced from S. uberis and S. parauberis synthesized higher MWHA, whereas those from S. pyogenes produced lower MWHA. In silico analysis of the HA synthase sequences indicated that differences in the transmembrane regions among the various isoforms are the probable cause of variations in MWHA. Compared to their wild-type counterparts, ldh-knockout L. lactis strains showed a noticeable increase in MWHA due to a substantial increase in HA precursor levels. Further, the co-expression of hasE in addition to hasAB, considerably increased MWHA due to a better balance of the intracellular HA-precursor ratios. This multiplexing approach, involving simultaneous manipulation of the above factors, allowed us to produce HA with tailored MWHA over a broad range from 0.2 to 2.6 MDa.
conclusionOur technology eliminates the need for enzymatic desizing or post-processing of HA to achieve the desired MWHA. In summary, this multiplexing approach enables one-pot synthesis of desired MWHA, opening up new avenues for producing customized HA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.